INNOVATION PHARMACEUTICALS INC. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ef39d927-9091-4899-971b-9a47d5d81f0c/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-3.1M | 2022-07-01 – 2023-06-30 | evidence 0001477932-23-007158 |
| FY 2022 | $-6.9M | 2021-07-01 – 2022-06-30 | evidence 0001477932-22-007292 |
| FY 2021 | $-9.0M | 2020-07-01 – 2021-06-30 | evidence 0001477932-21-006717 |
| FY 2020 | $-4.6M | 2019-07-01 – 2020-06-30 | evidence 0001477932-21-006717 |
| FY 2019 | $-6.5M | 2018-07-01 – 2019-06-30 | evidence 0001477932-19-005611 |
| FY 2018 | $-13.9M | 2017-07-01 – 2018-06-30 | evidence 0001477932-18-004457 |
| FY 2017 | $-15.3M | 2016-07-01 – 2017-06-30 | evidence 0001477932-17-004400 |
| FY 2016 | $-12.7M | 2015-07-01 – 2016-06-30 | evidence 0001477932-16-012448 |
| FY 2015 | $-13.0M | 2014-07-01 – 2015-06-30 | evidence 0001477932-15-005843 |
| FY 2014 | $-8.0M | 2013-07-01 – 2014-06-30 | evidence 0001477932-14-005027 |
| FY 2013 | $-23.0M | 2007-06-21 – 2014-03-31 | evidence 0001477932-14-002681 |
| FY 2012 | $-17.1M | 2007-06-21 – 2013-03-31 | evidence 0001548233-13-000008 |
| FY 2011 | $-13.7M | 2007-06-20 – 2012-03-31 | evidence 0001144204-12-030606 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
INNOVATION PHARMACEUTICALS INC. — all facts · Revenue · Net Income